First Time Loading...

Treace Medical Concepts Inc
NASDAQ:TMCI

Watchlist Manager
Treace Medical Concepts Inc Logo
Treace Medical Concepts Inc
NASDAQ:TMCI
Watchlist
Price: 11 USD 2.71% Market Closed
Updated: May 4, 2024

Treace Medical Concepts Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Treace Medical Concepts Inc
Revenue Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Treace Medical Concepts Inc
NASDAQ:TMCI
Revenue
$187.1m
CAGR 3-Years
48%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Revenue
$19.5B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Revenue
$14.7B
CAGR 3-Years
13%
CAGR 5-Years
8%
CAGR 10-Years
7%
Stryker Corp
NYSE:SYK
Revenue
$21B
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Revenue
$40.3B
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$7.3B
CAGR 3-Years
17%
CAGR 5-Years
14%
CAGR 10-Years
13%

See Also

What is Treace Medical Concepts Inc's Revenue?
Revenue
187.1m USD

Based on the financial report for Dec 31, 2023, Treace Medical Concepts Inc's Revenue amounts to 187.1m USD.

What is Treace Medical Concepts Inc's Revenue growth rate?
Revenue CAGR 3Y
48%

Over the last year, the Revenue growth was 32%. The average annual Revenue growth rates for Treace Medical Concepts Inc have been 48% over the past three years .